good evening!!

The world loves people who work hard at everything they do.

From my house to yours -- Happy Easter

The most powerful step in realizing your potential is simply to be present in the world.

What do you do when you are driving alone in a car?

You cannot find it anywhere, because it is located inside you… happiness is your natural state.

Every so called mistake is actually a rich source of learning.

[quote author=The Chairman link=topic=59655.msg491715#msg491715 date=1364758433]
The world loves people who work hard at everything they do.
[/quote][quote author=The Chairman link=topic=59655.msg491723#msg491723 date=1364762270]
You cannot find it anywhere, because it is located inside you… happiness is your natural state.
[/quote]  A rather profound silly statement , suggest  you visit a mental outpatient clinic

Sanctions Pushed Iran Inflation Dangerously High, Government Claims


More In Canada Business: College Grads In Min Wage... Ontario Being Bled Dry?... Arkansas Oil Spill...



Death Of The Coupon?


Ontario Teachers Reach Tentative Agreement


7 Industries Preying On Our Weaknesses


Ex-Reagan Adviser: Bush's Policies Bankrupt The Country


Study Reveals Shocking Truth About Shakespeare







Novartis Patent: India Rejects Bid For New Cancer Drug Version


CP  |  By Nirmala George, The Associated Press Posted: 04/01/2013 1:40 am EDT  |  Updated: 04/01/2013 11:01 am EDT











.







.








Get Canada Business Alerts:
Sign Up
..


Follow:

Video, Glivec India, India Supreme Court, Ranjit Shahani, Cancer Drug India, Cancer Drug Patent, Cancer Drugs India, Cipla, Glivec, India Cancer Drugs, India Supreme Court Patent, Novartis, Novartis Cancer Drug, Novartis India, Novartis Patent, Canada Business News
.










NEW DELHI - India's Supreme Court on Monday rejected drugmaker Novartis AG's attempt to patent a new version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.

Novartis had argued that it needed a patent to protect its investment in the cancer drug Glivec, while activists said the company was trying to use a loophole to make more money out of a drug that did not have a patent. The decision has global significance since India's $26-billion generic drug industry supplies much of the cheap medicine used in the developing world.

Pratibha Singh, a lawyer for the Indian generic drug manufacturer Cipla, which makes a version of Glivec for less than a tenth of the original drug's selling price, said the ruling sets a precedent that will prevent international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs.

The court ruled that a patent could only be given to a new drug, she told reporters outside the court.

"Patents will be given only for genuine inventions, and repetitive patents will not be given for minor tweaks to an existing drug," Singh said.

Novartis called the ruling a "setback for patients," and said patent protection is crucial to fostering investment in research to develop new and better drugs.

"We brought this case because we strongly believe patents safeguard innovation and encourage medical progress," said Ranjit Shahani, vice-chairman and managing director, Novartis India

was already there. they said i was sane

lets spice up the nite